Physical fitness and physical activity association with cognitive function and quality of life: baseline cross-sectional analysis of the PREDIMED-Plus trial.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 02 2020
Historique:
received: 09 07 2019
accepted: 27 01 2020
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 25 11 2020
Statut: epublish

Résumé

Physical activity (PA) has been hypothesized to be effective to maintaining cognitive function and delay cognitive decline in the elderly, but physical fitness (PF) could be a better predictor of cognitive function. We aimed to study the association between PA and PF with cognitive function and quality of life using cross-sectional data from 6874 participants of the PREDIMED-Plus trial (64.9 ± 4.9 years, 48.5% female). PF and PA were measured with a Chair Stand Test, the REGICOR and Rapid Assessment Physical Activity questionnaires. Cognitive function was measured with Mini-mental State Examination, Control Oral Word Association Test, Trail Making Test and Digit Span tests; whereas health-related quality of life was assessed with the SF36-HRQL test. Cognitive and quality of life scores were compared among PF quartiles and PA levels (low, moderate and high) with ANCOVA and with Chair Stand repetitions and energy expenditure from total PA with multivariable linear regression adjusted for confounding factors. PF associated with higher scores in phonemic and semantic verbal fluency tests and with lower TMT A time. However, PA was not associated with the neurocognitive parameters evaluated. Both PF and PA levels were strongly associated with a better quality of life. We concluded that PF, but not PA, is associated with a better cognitive function. This trial was retrospectively registered at the International Standard Randomized Controlled Trial (ISRCTN89898870, https://www.isrctn.com/ISRCTN89898870?q=ISRCTN89898870&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search) on 07/24/2014.

Identifiants

pubmed: 32103064
doi: 10.1038/s41598-020-59458-6
pii: 10.1038/s41598-020-59458-6
pmc: PMC7044289
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3472

Références

Nutr Rev. 2018 Jan 1;76(1):1-20
pubmed: 29240924
Psychosom Med. 2010 Apr;72(3):239-52
pubmed: 20223924
Clin Interv Aging. 2017 Oct 04;12:1627-1634
pubmed: 29042763
Eur J Cardiovasc Nurs. 2015 Aug;14(4):334-41
pubmed: 24829294
Ann Intern Med. 2018 Jan 2;168(1):52-62
pubmed: 29255909
Ann Epidemiol. 2011 Nov;21(11):857-63
pubmed: 21784658
Ageing Res Rev. 2016 Jan;25:85-101
pubmed: 26542489
Nature. 1999 Jul 29;400(6743):418-9
pubmed: 10440369
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886
Clin Geriatr Med. 2013 Nov;29(4):753-72
pubmed: 24094295
Arch Gerontol Geriatr. 2017 May - Jun;70:92-98
pubmed: 28110207
Sports Med. 2018 Jun;48(6):1405-1436
pubmed: 29667159
J Nutr Health Aging. 2017;21(6):637-647
pubmed: 28537327
JAMA Intern Med. 2015 Jul;175(7):1094-1103
pubmed: 25961184
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Dement Neuropsychol. 2017 Jan-Mar;11(1):6-14
pubmed: 29213488
Arch Phys Med Rehabil. 2004 Oct;85(10):1694-704
pubmed: 15468033
Atherosclerosis. 2014 May;234(1):47-53
pubmed: 24607853
Front Aging Neurosci. 2018 Mar 09;10:63
pubmed: 29593524
Med Clin (Barc). 1998 Oct 10;111(11):410-6
pubmed: 9834913
PLoS Med. 2017 Mar 21;14(3):e1002259
pubmed: 28323829
BMC Public Health. 2014 May 27;14:510
pubmed: 24885250
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
J Nutr Health Aging. 2013;17(6):544-52
pubmed: 23732551
J Strength Cond Res. 2007 Aug;21(3):973-8
pubmed: 17685726
Hippocampus. 2009 Oct;19(10):1030-9
pubmed: 19123237
Neurobiol Aging. 1984 Spring;5(1):35-42
pubmed: 6738784
Res Q Exerc Sport. 1999 Jun;70(2):113-9
pubmed: 10380242
Cochrane Database Syst Rev. 2015 Apr 22;(4):CD005381
pubmed: 25900537
Arch Clin Neuropsychol. 2009 Jun;24(4):321-41
pubmed: 19661109
Ann Behav Med. 2008 Dec;36(3):280-91
pubmed: 18825471
Phys Ther. 2017 Oct 1;97(10):975-984
pubmed: 29029554
Psychiatry Res. 2014 Oct 30;219(2):361-6
pubmed: 24929440
Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17(3):162-7
pubmed: 14512830
Psychol Sci. 2003 Mar;14(2):125-30
pubmed: 12661673
Neural Plast. 2017;2017:3589271
pubmed: 28695017
Gac Sanit. 2005 Mar-Apr;19(2):135-50
pubmed: 15860162
Ann Epidemiol. 2010 Apr;20(4):251-7
pubmed: 20171901
PLoS One. 2018 Jun 18;13(6):e0198974
pubmed: 29912978
Psychiatry Res. 2017 Oct;256:219-224
pubmed: 28646785
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1318-25
pubmed: 23670794
Eur J Appl Physiol. 2010 Jul;109(4):617-24
pubmed: 20186426
Braz J Psychiatry. 2014 Jan-Mar;36(1):76-88
pubmed: 24554274
Sci Rep. 2018 Oct 31;8(1):16128
pubmed: 30382190
J Hepatol. 2017 Jan;66(1):142-152
pubmed: 27639843
Age (Dordr). 2015;37(2):25
pubmed: 25773069
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22
pubmed: 21282661
Age Ageing. 2012 Nov;41 Suppl 3:iii41-5
pubmed: 23144287
Arch Clin Neuropsychol. 1996;11(4):329-38
pubmed: 14588937
J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):480-6
pubmed: 25147086
Neurosci Biobehav Rev. 2018 May;88:177-186
pubmed: 29572187
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123

Auteurs

Lidia Daimiel (L)

Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain. lidia.daimiel@imdea.org.

Miguel A Martínez-González (MA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, Spain.
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, USA.

Dolores Corella (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Jordi Salas-Salvadó (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició. Hospital Universitari San Joan de Reus, Institut d'Investigació Pere Virgili (IISPV), Reus, Spain.

Helmut Schröder (H)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

Jesús Vioque (J)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, ISABIAL, Alicante, Spain.

Dora Romaguera (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

J Alfredo Martínez (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Nutrition, Food Sciences, and Physiology, University of Navarra, Pamplona, Spain.
Cardiometabolic Nutrition Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

Julia Wärnberg (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Nursing, School of Health Sciences, University of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.

Jose Lopez-Miranda (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.

Ramón Estruch (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Naomi Cano-Ibáñez (N)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Granada, Granada, Spain.

Angel Alonso-Gómez (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital; University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.

Josep A Tur (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.

Francisco J Tinahones (FJ)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Instituto de Investigación Biomédica de Málaga (IBIMA), Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain.

Lluis Serra-Majem (L)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Preventive Medicine Service, Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service., Las Palmas, Spain.

Rafael M Micó-Pérez (RM)

Cátedra cronicidad Universidad Miguel Hernández, Fundación, Semergen, Spain.

José Lapetra (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.

Alba Galdón (A)

Department of Endocrinology, Fundación Jiménez-Díaz, Madrid, Spain.

Xavier Pintó (X)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Josep Vidal (J)

CIBER Diabetes y enfermedades metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Victor Micó (V)

Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

Gonzalo Colmenarejo (G)

Biostatistics and Bioinformatics Unit, IMDEA Food, CEI UAM+CSIC, Madrid, Spain.

José J Gaforio (JJ)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaén, Jaén, Spain.

Pilar Matía (P)

Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Emilio Ros (E)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Pilar Buil-Cosiales (P)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Primary Health Care. Servicio Navarro de Salud, Pamplona, Spain.

Zenaida Vázquez-Ruiz (Z)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, Spain.

José V Sorlí (JV)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Indira Paz Graniel (IP)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició. Hospital Universitari San Joan de Reus, Institut d'Investigació Pere Virgili (IISPV), Reus, Spain.

Aida Cuenca-Royo (A)

Integrative Pharmacology and Systems Neurosciences Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

Cristina Gisbert-Sellés (C)

Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.
Primary Health Care Center San Vicente del Raspeig, Alicante, Spain.

Aina M Galmes-Panades (AM)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

M Angeles Zulet (MA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Nutrition, Food Sciences, and Physiology, University of Navarra, Pamplona, Spain.
Cardiometabolic Nutrition Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

Antonio García-Ríos (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.

Andrés Díaz-López (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició. Hospital Universitari San Joan de Reus, Institut d'Investigació Pere Virgili (IISPV), Reus, Spain.

Rafael de la Torre (R)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

Iñigo Galilea-Zabalza (I)

Primary Health Care. Servicio Navarro de Salud, Pamplona, Spain.

José M Ordovás (JM)

Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.
Nutrition and Genomics Laboratory, JM_USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, 02111, USA.
Department of Cardiovascular Epidemiology and Population Genetics, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH